SN

Sathvik Nalluri

Active Director Director DIN 10498064
DIN 10498064 First appointment Feb 2024 Primary industry Service
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2024
Shareholding value •••• Premium profile

About Sathvik Nalluri

Data last updated:

Sathvik Nalluri is a Director at Bhan Pharmainfo Private Limited (since 2024). The company operates in Service. Bhan Pharmainfo Private Limited reported revenue of ₹13.6 Lakh (FY 2025).

DIN 10498064
Primary Designation Director
Industry Service
First Appointment 15 Feb 2024
Oldest Company Age 19 yrs
Largest company Bhan Pharmainfo Private Limited · ₹13.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bhan Pharmainfo Private Limited U24232TG2007PTC054050
Director15 Feb 20242007₹13.6 Lakh (FY 2025)Active

Board colleagues of Sathvik Nalluri

Directorship timeline

Open interactive timeline →
Bhan Pharmainfo Private Limited
Premium access

Shareholding and investment profile for Sathvik Nalluri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sathvik Nalluri

Sathvik Nalluri currently holds 1 directorship: Bhan Pharmainfo Private Limited (Director, since 15 Feb 2024, revenue ₹13.6 Lakh (FY 2025)).

Sathvik Nalluri was first appointed on 15 Feb 2024 as Director at Bhan Pharmainfo Private Limited.

The current boards of Sathvik Nalluri's companies include Bhanu Prasad Kommineni (Bhan Pharmainfo Private Limited), Kavitha Chundu (Bhan Pharmainfo Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available